Medical management of cerebral vasospasm: Present and future

Neurological Research

Volumn 31, Issue 6, 2009, Pages 626-631

  Zubkov, Alexander Y ^a   Rabinstein, Alejandro A ^a,b  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

Cerebral vasospasm; Diagnosis; Subarachnoid hemorrhage; Treatment

Indexed keywords

ALBUMIN; CALCIUM CHANNEL BLOCKING AGENT; CLAZOSENTAN; FLUDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM SULFATE; NIMODIPINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PLACEBO; PRAVASTATIN; SIMVASTATIN;

BLOOD TRANSFUSION; BRAIN VASOSPASM; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONVENTIONAL ANGIOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOGRAPHY; ENTERIC FEEDING; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SUBARACHNOID HEMORRHAGE;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MAGNESIUM SULFATE; NITRIC OXIDE; RECEPTORS, ENDOTHELIN; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 68149159152     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X382331     Document Type: Review

References (77)

1. Huang J, van Gelder JM. The probability of sudden death from rupture of intracranial aneurysms: A meta-analysis. Neurosurgery 2002; 51 (5): 1101-1105 (Pubitemid 36322696)
2. Hop JW, Rinkel GJE, Algra A, et al. Case-fatality rates and functional outcome after subarachnoid hemorrhage: A systematic review. Stroke 1997; 28 (3): 660-664 (Pubitemid 27118394)
3. Stegmayr B, Eriksson M, Asplund K. Declining mortality from subarachnoid hemorrhage: Changes in incidence and case fatality from 1985 through 2000. Stroke 2004; 35 (9): 2059-2063
4. Kassell N, Torner J. The International Cooperative Study on Timing of Aneurysm Surgery - an update. Stroke 1984; 15 (3): 566-570 (Pubitemid 14105977)
5. Anderson GB, Ashforth R, Steinke DE, et al. CT angiography for the detection of cerebral vasospasm in patients with acute subarachnoid hemorrhage. AJNR Am J Neuroradiol 2000; 21 (6): 1011-1015 (Pubitemid 30390533)
6. Kassell N, Sasaki T, Colohan A, et al. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985; 16 (4): 562-572 (Pubitemid 15007226)
7. Baldwin ME, Macdonald RL, Huo D, et al. Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke 2004; 35 (11): 2506-2511 (Pubitemid 39458408)
8. Dorsch NWC, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage. Part I: Incidence and effects. J Clin Neurosci 1994; 1 (1): 19-26
9. Macdonald RL. Management of cerebral vasospasm. Neurosurg Rev 2006; 29 (3): 179-193
10. Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: The modified fisher scale. Neurosurgery 2006; 59 (1): 21-27 (Pubitemid 44024334)
11. Reilly C, Amidei C, Tolentino J, et al. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 2004; 101 (2): 255-261 (Pubitemid 38971001)
12. Rosen DS, Amidei C, Tolentino J, et al. Subarachnoid clot volume correlates with age, neurological grade, and blood pressure. Neurosurgery 2007; 60 (2): 259-266 (Pubitemid 46253786)
13. Fisher CM, Roberson GH, Ojemann RG. Cerebral vasospasm with ruptured saccular aneurysm--the clinical manifestations. Neurosurgery 1977; 1 (3): 245-248
14. Sloan MA, Alexandrov AV, Tegeler CH, et al. Assessment: Transcranial Doppler ultrasonography: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2004; 62 (9): 1468-1481 (Pubitemid 38608182)
15. Suarez JI, Qureshi AI, Yahia AB, et al. Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: Evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution. Crit Care Med 2002; 30 (6): 1348-1355
16. Wintermark M, Ko NU, Smith WS, et al. Vasospasm after subarachnoid hemorrhage: Utility of perfusion CT and CT angiography on diagnosis and management. AJNR Am J Neuroradiol 2006; 27 (1): 26-34 (Pubitemid 46939879)
17. Sloan MA, Haley EC, Jr, Kassell NF, et al. Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage. Neurology 1989; 39 (11): 1514-1518
18. Vora YY, Suarez-Almazor M, Steinke DE, et al. Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1999; 44 (6): 1237-1247 (Pubitemid 29252743)
19. Lindegaard KF, Nornes H, Bakke SJ, et al. Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien) 1989; 100 (1-2): 12-24 (Pubitemid 19247138)
20. Sloan MA, Burch CM, Wozniak MA, et al. Transcranial Doppler detection of vertebrobasilar vasospasm following subarachnoid hemorrhage. Stroke 1994; 25 (11): 2187-2197 (Pubitemid 24338374)
21. Sviri GE, Lewis DH, Correa R, et al. Basilar artery vasospasm and delayed posterior circulation ischemia after aneurysmal subarachnoid hemorrhage. Stroke 2004; 35 (8): 1867-1872 (Pubitemid 38971867)
22. Sviri GE, Ghodke B, Britz GW, et al. Transcranial Doppler grading criteria for basilar artery vasospasm. Neurosurgery 2006; 59 (2): 360-366 (Pubitemid 44334826)
23. Sviri GE, Britz GW, Lewis DH, et al. Dynamic perfusion computed tomography in the diagnosis of cerebral vasospasm. Neurosurgery 2006; 59 (2): 319-325
24. Sanelli PC, Ougorets I, Johnson CE, et al. Using CT in the diagnosis and management of patients with cerebral vasospasm. Semin Ultrasound CT MR 2006; 27 (3): 194-206 (Pubitemid 43831565)
25. Otawara Y, Ogasawara K, Ogawa A, et al. Evaluation of vasospasm after subarachnoid hemorrhage by use of multislice computed tomographic angiography. Neurosurgery 2002; 51 (4): 939-942 (Pubitemid 36331029)
26. Zubkov AY, Raila FA, Lewis AI, et al. Use of CT angiography in detection of cerebral vasospasm. J Neurovasc Dis 1998; 3 (6): 257-262
27. Ochi RP, Vieco PT, Gross CE. CT angiography of cerebral vasospasm with conventional angiographic comparison. AJNR Am J Neuroradiol 1997; 18 (2): 265-269 (Pubitemid 27082202)
28. Moftakhar R, Rowley HA, Turk A, et al. Utility of computed tomography perfusion in detection of cerebral vasospasm in patients with subarachnoid hemorrhage. Neurosurg Focus 2006; 21 (3): E6
29. Rabinstein AA, Friedman JA, Weigand SD, et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004; 35 (8): 1862-1866 (Pubitemid 38971866)
30. Rabinstein AA, Weigand S, Atkinson JL, et al. Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2005; 36 (5): 992-997 (Pubitemid 40629290)
31. Hadeishi H, Suzuki A, Yasui N, et al. Diffusion-weighted magnetic resonance imaging in patients with subarachnoid hemorrhage. Neurosurgery 2002; 50 (4): 741-747 (Pubitemid 36322798)
32. Weidauer S, Lanfermann H, Raabe A, et al. Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage. A prospective MRI and DSA study. Stroke 2007; 106: 477-976.
33. Griffiths PD, Wilkinson ID, Mitchell P, et al. Multimodality MR imaging depiction of hemodynamic changes and cerebral ischemia in subarachnoid hemorrhage. AJNR Am J Neuroradiol 2001; 22 (9): 1690-1697 (Pubitemid 32999578)
34. Rordorf G, Koroshetz WJ, Copen WA, et al. Diffusion- and perfusion-weighted imaging in vasospasm after subarachnoid hemorrhage. Stroke 1999; 30 (3): 599-605 (Pubitemid 29115398)
35. Brisman JL, Eskridge JM, Newell DW. Neurointerventional treatment of vasospasm. Neurol Res 2006; 28 (7): 769-776
36. Mayer SA, Solomon RA, Fink ME, et al. Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage. Neurosurgery 1998; 42 (4): 759-767
37. Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: A randomized controlled trial. Stroke 2000; 31 (2): 383-391 (Pubitemid 30078170)
38. Egge A, Waterloo K, Sjoholm H, et al. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: A clinical, prospective, randomized, controlled study. Neurosurgery 2001; 49 (3): 593-605 (Pubitemid 32769748)
39. Sen J, Belli A, Albon H, et al. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol 2003; 2 (10): 614-621 (Pubitemid 37162570)
40. Kassell NF, Peerless SJ, Durward QJ, et al. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982; 11 (3): 337-343
41. Corsten L, Raja A, Guppy K, et al. Contemporary management of subarachnoid hemorrhage and vasospasm: The UIC experience. Surg Neurol 2001; 56 (3): 140-148 (Pubitemid 32946842)
42. Rinkel GJ, Feigin VL, Algra A, et al. Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2004; (4): CD000483
43. Suarez JI, Shannon L, Zaidat OO, et al. Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. J Neurosurg 2004; 100 (4): 585-590 (Pubitemid 38372836)
44. Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25 (11): 2315-2328
45. Feigin VL, Rinkel GJ, Algra A, et al. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: A systematic review. Neurology 1998; 50 (4): 876-883 (Pubitemid 28212809)
46. Haley EC, Jr, Kassell NF, Torner JC. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 1993; 78 (4): 537-547 (Pubitemid 23099461)
47. Rabinstein AA, Wijdicks EF. Cerebral vasospasm in subarachnoid hemorrhage. Curr Treat Options Neurol 2005; 7 (2): 99-107
48. Pluta RM. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Neurol Res 2006; 28 (7): 730-737
49. McGirt MJ, Lynch JR, Parra A, et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002; 33 (12): 2950-2956 (Pubitemid 35462871)
50. Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005; 45: 89-118
51. Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: Results of a pilot randomized clinical trial. Stroke 2005; 36 (9): 2024-2026 (Pubitemid 41266547)
52. Tseng M-Y, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: A phase II randomized placebo-controlled trial. Stroke 2005; 36 (8): 1627-1632 (Pubitemid 41098752)
53. Tseng M-Y, Hutchinson PJ, Czosnyka M, et al. Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 2007; 38 (5): 1545-1550 (Pubitemid 46684172)
54. Zubkov AY, Nanda A, Zhang JH. Signal transduction pathways in cerebral vasospasm. Pathophysiology 2003; 9 (2): 47-61 (Pubitemid 37297327)
55. Zubkov AY, Rollins KS, Parent AD, et al. Mechanism of endothelin-1-induced contraction in rabbit basilar artery. Stroke 2000; 31 (2): 526-533 (Pubitemid 30078192)
56. Vajkoczy P, Meyer B, Weidauer S, et al. Clazosentan (AXV- 034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: Results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 2005; 103 (1): 9-17 (Pubitemid 43193928)
57. Macdonald RL, Kassell NF, Mayer SA, et al. Randomized trial of clazosentan for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2007; 38 (2): a453-a607
58. Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: The emerging revolution. Nat Clin Pract Neurol 2007; 3 (5): 256-263 (Pubitemid 46745473)
59. van den Bergh WM, Algra A, van der Sprenkel JW, et al. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003; 52 (2): 276-281
60. Iseri LT, French JH. Magnesium: Nature's physiologic calcium blocker. Am Heart J 1984; 108 (1): 188-193
61. Ram Z, Sadeh M, Shacked I, et al. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 1991; 22 (7): 922-927
62. Marinov MB, Harbaugh KS, Hoopes PJ, et al. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg 1996; 85 (1): 117-124
63. Boet R, Mee E. Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: A pilot study. Neurosurgery 2000; 47 (3): 602-606 (Pubitemid 32044706)
64. Veyna RS, Seyfried D, Burke DG, et al. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002; 96 (3): 510-514 (Pubitemid 34230205)
65. van den Bergh WM, Algra A, van Kooten F, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: A randomized controlled trial. Stroke 2005; 36 (5): 1011-1015 (Pubitemid 40629294)
66. van den Bergh WM, Mees SM, Rinkel GJ. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: A randomized study. Neurosurgery 2006; 59 (5): E1152
67. Clark FL, White RP. Endothelium and cerebral vasospasm. J Neurosurg 1989; 70 (4): 657-659
68. Zubkov AY, Tibbs RE, Clower B, et al. Morphological changes of cerebral arteries in a canine double hemorrhage model. Neurosci Lett 2002; 326 (2): 137-141 (Pubitemid 34607578)
69. Kanamaru K, Waga S, Kojima T, et al. Endothelium-dependent relaxation of canine basilar arteries. Part 2: Inhibition by hemoglobin and cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Stroke 1987; 18 (5): 938-943
70. Pluta RM, Afshar JK, Thompson BG, et al. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage. J Neurosurg 2000; 92 (1): 121-126
71. Tanazawa T, Suzuki Y, Anzai M, et al. Vasodilation by intrathecal lipopolysaccharide of the cerebral arteries after subarachnoid haemorrhage in dogs. Acta Neurochir (Wien) 1996; 138 (3): 330-337 (Pubitemid 26096793)
72. Afshar JK, Pluta RM, Boock RJ, et al. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1995; 83 (1): 118-122
73. Pluta RM, Oldfield EH, Boock RJ. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 1997; 87 (5): 746-751 (Pubitemid 27454594)
74. Sehba FA, Friedrich V, Jr, Makonnen G, et al. Acute cerebral vascular injury after subarachnoid hemorrhage and its prevention by administration of a nitric oxide donor. J Neurosurg 2007; 106 (2): 321-329
75. Thomas JE, Rosenwasser RH. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: Initial observations regarding the use of intraventricular sodium nitroprusside in humans. Neurosurgery 1999; 44 (1): 48-57
76. Vajkoczy P, Hubner U, Horn P, et al. Intrathecal sodium nitroprusside improves cerebral blood flow and oxygenation in refractory cerebral vasospasm and ischemia in humans. Stroke 2000; 31 (5): 1195-1197 (Pubitemid 30253547)
77. Raabe A, Zimmermann M, Setzer M, et al. Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm. Neurosurgery 2002; 50 (5): 1006-1013 (Pubitemid 36331136)